Reperfusion in Patients With Renal Dysfunction After Presentation With ST-Segment Elevation or Left Bundle Branch Block. GRACE (Global Registry of Acute Coronary Events)

JACC: Cardiovascular Interventions

Volumn 2, Issue 1, 2009, Pages 26-33

  Medi, Caroline ^a   Montalescot, Gilles ^b   Budaj, Andrzej ^c   Fox, Keith A A ^d   López Sendón, José ^e   FitzGerald, Gordon ^f   Brieger, David B ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c GROCHOWSKI HOSPITAL   (Poland)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

fibrinolysis; left bundle branch block; percutaneous coronary intervention; renal dysfunction; ST segment elevation

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE REPERFUSION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STROKE; ACUTE CORONARY SYNDROME; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HEART BUNDLE BRANCH BLOCK; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGISTER; RISK; RISK REDUCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BUNDLE-BRANCH BLOCK; CONFIDENCE INTERVALS; FEMALE; FIBRINOLYTIC AGENTS; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ODDS RATIO; PROSPECTIVE STUDIES; REGISTRIES; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

FIBRINOLYTIC AGENT;

EID: 58249117754     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.09.010     Document Type: Article

References (33)

1. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
2. Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106 (2002) 974-980
3. Schillaci G., Reboldi G., and Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 161 (2001) 886-891
4. Meisinger C., Doring A., and Lowel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women form the general population. Eur Heart J 27 (2006) 1245-1250
5. Go A.S., and Lo J.C. Epidemiology of non dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens 15 (2006) 296-302
6. Martinez-Vera A., Salvado E., Bardaji A., et al. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with chronic kidney disease. Am J Kidney Dis 47 (2006) 241-250
7. Afshinnia F., Ayazi P., and Chadow H.L. Glomerular filtration rate on admission independently predicts short term in-hospital mortality after acute myocardial infarction. Am J Nephrol 26 (2006) 408-414
8. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
9. Walsh C.R., O'Donnell C.J., Camargo C.A., Guigliano R.P., and Lloyd-Jones D.M. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144 (2002) 1003-1011
10. Hemmelgarn B.R., Southern D., Culleton B.F., Mitchell L.B., Knudtson M.L., and Ghali W.A. Survival after coronary revascularization among patients with kidney disease. Circulation 110 (2004) 1890-1895
11. Ix J.H., Mercado N., Shlipak M.G., et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 149 (2005) 512-519
12. Szczech L.A., Best P.J., Crowley E., et al. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 105 (2002) 2253-2258
13. Coca S.G., Krumholz H.M., Garg A.X., and Parikh C.R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296 (2006) 1377-1384
14. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., and Palacios I.F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 (2000) 2966-2972
15. Newsome B.B., Warnock D.G., Kiefe C.I., et al. Delay in time to receipt of thrombolytic medication among Medicare patients with kidney disease. Am J Kidney Dis 46 (2005) 595-602
16. Investigators T.G. Rationale and design of the GRACE (Global Registry of ACute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 141 (2001) 190-199
17. Steg P.G., Goldberg R.J., Gore J.M., et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90 (2002) 358-363
18. Hallan S., Asberg A., Lindberg M., and Johnsen H. Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 44 (2004) 84-93
19. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 163 (2003) 2345-2353
20. Eagle K.A., Lim M.J., Budaj A., et al. A robust prediction model for all forms of acute coronary syndromes: estimating the risk of in-hospital death and myocardial infarction in the Global Registry of Acute Coronary Events Registry. J Am Coll Cardiol 41 (2003) 353A
21. McCullough P.A., Soman S.S., Shah S.S., et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 36 (2000) 679-684
22. Beattie J.N., Soman S.S., Sandberg K.R., et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37 (2001) 1191-1200
23. Fox K.A.A., Anderson F.A.J., Dabbous O.H., et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics?. The Global Registry of Acute Coronary Events (GRACE). Heart 93 (2007) 177-182
24. Herzog C.A., Littrell K., Arko C., Frederick P.D., and Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarctions in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116 (2007) 1465-1472
25. Attallah N., Yassine L., Fisher K., and Yee J. Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. Clin Nephrol 64 (2005) 412-418
26. Spencer F.A., Moscucci M., Granger C.B., et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?. Circulation 116 (2008) 2793-2801
27. Agostoni P., Biondi-Zoccai G.G.L., Benedictis M.L.D., et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 44 (2004) 349-356
28. Montalescot G., White H.D., Gallo R., et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 355 (2006) 1006-1017
29. Dumaine R., Borentain M., Bertel O., et al. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary interventions: quantitative review or randomized trials. Arch Intern Med 167 (2007) 2423-2430
30. Lincoff A.M., Bittl J.A., Harrington R.A., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. JAMA 289 (2003) 853-863
31. Manoukian S.V., Feit F., Mehran R., et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49 (2007) 1362-1368
32. Steg P.G., Lopez-Sendon J., Loez de Sa E., et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 167 (2007) 68-73
33. Keeley E.C., Kadakia R., Soman S., Borzak S., and McCullough P.A. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92 (2003) 509-514